Evolus, Inc. (EOLS)
7.14
-0.55
(-7.15%)
USD |
NASDAQ |
Oct 02, 16:00
7.135
0.00 (0.00%)
After-Hours: 20:00
Evolus Gross Profit Margin (Quarterly) : 66.18% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.18% |
| March 31, 2026 | 64.75% |
| December 31, 2025 | 64.06% |
| September 30, 2025 | 64.81% |
| June 30, 2025 | 63.97% |
| March 31, 2025 | 66.89% |
| December 31, 2024 | 62.03% |
| September 30, 2024 | 68.39% |
| June 30, 2024 | 69.36% |
| March 31, 2024 | 67.18% |
| December 31, 2023 | 66.16% |
| September 30, 2023 | 66.53% |
| June 30, 2023 | 67.66% |
| March 31, 2023 | 68.01% |
| December 31, 2022 | 67.01% |
| Date | Value |
|---|---|
| September 30, 2022 | 57.49% |
| June 30, 2022 | 55.14% |
| March 31, 2022 | 58.33% |
| December 31, 2021 | 51.66% |
| September 30, 2021 | 53.47% |
| June 30, 2021 | 50.00% |
| March 31, 2021 | 43.30% |
| December 31, 2020 | 55.51% |
| September 30, 2020 | 62.64% |
| June 30, 2020 | 53.80% |
| March 31, 2020 | 43.14% |
| December 31, 2019 | 73.75% |
| September 30, 2019 | 62.63% |
| June 30, 2019 | 29.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -15.03% |
| Return on Invested Capital | -25.84% |
| Profit Margin (Quarterly) | -9.58% |
| Operating Margin (Quarterly) | -3.92% |
| Return on Net Operating Assets | -19.73% |